JUNE 2022
Peter Kolchinsky, PhD | Tess Cameron | Dan Lepanto
Join Peter Kolchinsky (Managing Partner, RA Capital), Tess Cameron (Principal, RA Capital), and Dan Lepanto (Senior Managing Director, SVB Securities) for a candid discussion on the array of tools a biotech board can employ in the midst of the current market downturn (June 2022).
Slides are available here.
Our website uses cookies to distinguish you from other users of our website. This helps us to provide you with a good experience when you browse our website, and also allows us to improve our site. By continuing, you accept the use of these cookies.
dismiss